The forward P/E of 10.1x implies the market expects earnings growth, but the PEG of 1.06 suggests the growth is fairly valued relative to the multiple. Compared to peers like Infosys at 15.1x and Wipro at 15.1x, CTSH's discount may reflect its lower ROE (around 17% annualized) versus Infosys's 32.8%, indicating the market is pricing in a structural growth disadvantage. The EV/EBITDA of 6.4x is near EPAM's 6.1x, but CTSH's larger scale and diversified offerings may warrant a premium, which is not evident.

Gross margin fluctuated between 29.6% and 35.1%, with Q2 2026 at 33.4%, indicating cost variability likely from wage inflation and utilization. The operating margin expansion from 14.6% in early 2024 to 15.9% suggests cost discipline, but the net margin volatility—dropping to 5.1% in Q3 2025—highlights non-recurring items that distort true profitability. Adjusted for these items, the sustainable net margin appears closer to 11-12%, which is competitive but below Infosys's 16.4%, suggesting CTSH may have less pricing power or higher cost structure.

ROE and ROIC have been stable but unspectacular, with quarterly ROIC around 4.3% in Q2 2026. The stability suggests the company is not compounding returns, but rather maintaining a steady state. The gap to peers may stem from a higher asset base due to acquisitions, as goodwill now constitutes 39% of total assets, diluting returns on capital. If the company can integrate acquisitions effectively, returns could improve, but the current trend suggests a mature business with limited upside in capital efficiency.

The stable DSO suggests consistent collection practices, but the absence of DIO and DPO data limits analysis of supplier leverage and inventory management. Given the asset-light model, inventory is likely minimal, but the lack of DPO data prevents assessment of how CTSH manages payables to optimize cash flow. The extreme swings in operating cash flow, as noted in prior analysis, may be partly due to working capital timing, but without full data, investors should monitor cash conversion trends as more information becomes available.

Total debt increased from $1.3B to $2.1B, but the absolute level is modest relative to equity and EBITDA. Interest coverage of 68x in Q2 2026 is robust, suggesting no near-term solvency risk. However, the rising D/E and D/EBITDA (from 1.14 to 2.36) indicate a deliberate shift toward debt financing, possibly for acquisitions or buybacks. If this trend continues, coverage could erode, but current levels are far from concerning. The company's cash position has declined to $1.0B, so the increased debt may be partly to fund capital returns.

The current ratio remains above 2.0, suggesting CTSH can cover short-term obligations comfortably. However, the decline in cash and the rise in debt indicate a tighter liquidity position. Under a severe stress scenario, such as a prolonged revenue downturn, the company might need to rely on credit lines or reduce capital returns. The quick ratio equals the current ratio, implying minimal inventory, which is typical for a services firm. Investors should monitor whether cash generation improves to rebuild the buffer, especially given the volatile FCF margins.